Search
Neuraxis Inc
NRXSAdd to Watchlist
6.790USD
-0.210-3.00%
Close 06/24, 16:00（ET）Quotes delayed by 15 min
77.75MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-23The current earnings forecast score of Neuraxis Inc is 8.00, ranking 66 out of 204 in the Healthcare Equipment & Supplies industry.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
11.000
Target Price
0.00%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
Neuraxis Inc
NRXS
2
Medtronic PLC
MDT
34
Dexcom Inc
DXCM
32
Stryker Corp
SYK
32
Abbott Laboratories
ABT
31
Zimmer Biomet Holdings Inc
ZBH
31
1
2
3
...
24
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Neuraxis Inc's expected revenue for the next quarter?
Neuraxis Inc's expected revenue is 2.00M.
How have Neuraxis IncNRXS's recent earnings per share performed?
The market expectation was USD -0.18, while Neuraxis IncNRXS's earnings per share (EPS) for the previous quarter was USD -0.18. EPS for the next quarter is expected at USD -0.32.
What is the analyst rating for Neuraxis Inc?
Based on the ratings of Neuraxis Inc's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
